Skip to content

Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study

Comparative Assessment of Reflux Esophagitis in Cases With and Without Esophageal Motility Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06835374
Enrollment
200
Registered
2025-02-19
Start date
2024-05-11
Completion date
2027-05-10
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Diseases

Brief summary

Achalasia is a neuro-degenerative disorder marked by changes in the peristalsis of the esophagus and the lack of relaxation in the lower esophageal sphincter (LES), thought to be due to damage to the myenteric plexus with an unknown cause.1 Per-oral endoscopic myotomy (POEM) is an established endoscopic treatment modality for achalasia. Leading gastrointestinal (GI) societies endorse POEM as one of the primary treatment option for achalasia.This study aims to characterize and compare the morphological characteristics of reflux related erosions after the POEM procedures versus those in cases without esophageal motility disorders. Data collection 1. Demographic characteristics: Age, gender, type of achalasia 2. Manometry findings (pre and post POEM): integrated relaxation pressure, lower esophageal sphincter pressure 3. Comorbidities 4. Medications 5. Eckardt score: before procedure and 3-months after Procedure 6. POEM procedure details: length of esophageal and gastric myotomy, adverse events, length of hospital stay 7. Evaluation at 3-months Symptom: standardized questionnaire (GERDQ) Endoscopy: grade of esophagitis Erosions vs ulcers Dimension of erosions Anatomical location (according to clock)

Detailed description

POEM will be performed using a standardized technique.8 The patients will be prescribed a single dose anti-secretory medicine (equivalent to 40 mg esomeprazole) for two months after POEM. Consecutive patients who meet the inclusion and exclusion criteria will be followed up after 3 months. PPIs will be discontinued for at least 4 weeks prior to objective evaluation of GERD. Each patient returning after 3 months for follow up will undergo several follow up examinations, including GERD questionnaire scoring, Esophagogastroduodenoscopy, 24 hour pH impedance test. Presence of endoscopically visible esophagitis . Endoscopic findings such as anatomical location, dimensions of the mucosal breaks will be compared to general population with diagnosis of GERD who have endoscopically visible esophagitis.

Interventions

PROCEDUREPer oral endoscopy myotomy (Per oral endoscopy myotomy)

POEM is the procedure to reduce the symptoms of dysphagia, regurgitation.

PROCEDUREEndoscopy procedure

Endoscopy procedure is required to rule out type of reflux disease

Sponsors

Asian Institute of Gastroenterology, India
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age≥18y, 2. confirmed diagnosis of Achalasia, 3. No contraindication to POEM, 4. erosive esophagitis on endoscopy

Exclusion criteria

1. Non-esophageal esophageal motility disorders, 2. Treatment other than POEM, 3. current PPI use before assessment for GERD

Design outcomes

Primary

MeasureTime frameDescription
comparison of reflux esophagitis in cases who undergo POEM procedure versus those without esophageal motility disorders3 monthsReflux esophagitis can be calculated as grade B category (red colour scar found in esophagus mucosa) during endoscopy procedure
Assessment of the , esophageal acid exposure6 monthsesophageal acid exposure is a value indicates higher reflux can be calculated in ph impedence report

Countries

India

Contacts

CONTACTRajesh Goud Mr Maragoni, M.Pharm, MBA
rajeshgoud761@gmail.com04023378888
CONTACTZaheer Nabi Dr Mohammed, MBBS MD
zaheernabi1978@gmail.com04023378888
PRINCIPAL_INVESTIGATORZaheer Nabi Dr Mohammed, MBBS MD

AIG Hospitals

PRINCIPAL_INVESTIGATORChinmay Dr Hegde, MBBS MD

AIG Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026